Allogene’s Off-the-Shelf CAR-T Wipes Out Hidden Cancer Cells in 58% of High-Risk Lymphoma Patients – Early Trial Success
Allogene’s CAR-T cema-cel showed strong early results in lymphoma, removing hidden cancer better than watchful waiting with good safety.
